| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |